Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2026-02-25 @ 12:56 AM
Study NCT ID:
NCT04984434
Status:
UNKNOWN
Last Update Posted:
2021-07-30
First Post:
2021-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Shandong New Time Pharmaceutical Co., LTD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma | View |
Keywords: